Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
about
The modulation of carbonyl reductase 1 by polyphenols.ABCG2 and NCF4 polymorphisms are associated with clinical outcomes in diffuse large B-cell lymphoma patients treated with R-CHOP.Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients.
P2860
Single nucleotide polymorphisms in ABCB1 and CBR1 can predict toxicity to R-CHOP type regimens in patients with diffuse non-Hodgkin lymphoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@en
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@nl
type
label
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@en
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@nl
prefLabel
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@en
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@nl
P2093
P2860
P50
P1433
P1476
Single nucleotide polymorphism ...... diffuse non-Hodgkin lymphoma.
@en
P2093
Delphine Demangel
Fabrice Jardin
Gilles A Salles
Hervé Ghesquieres
Hervé Tilly
Richard Delarue
Sophie Pallardy
Vincent Ribrag
P2860
P304
P356
10.3324/HAEMATOL.2014.120113
P577
2015-01-30T00:00:00Z